Browse > Article

Correlation Between NT-proBNP and Pulmonary Arterial Pressure in COPD Patients  

Hwang, Yong Il (Department of Internal Medicine, Seoul National University, College of Medicine, Lung Institute of Seoul National University Medical Research Center)
Park, Geun Min (Department of Internal Medicine, Seoul National University, College of Medicine, Lung Institute of Seoul National University Medical Research Center)
Kwon, Sung Youn (Department of Internal Medicine, Seoul National University, College of Medicine, Lung Institute of Seoul National University Medical Research Center)
Yoon, Ho Il (Department of Internal Medicine, Seoul National University, College of Medicine, Lung Institute of Seoul National University Medical Research Center)
Lee, Choon-Taek (Department of Internal Medicine, Seoul National University, College of Medicine, Lung Institute of Seoul National University Medical Research Center)
Han, Sung Koo (Department of Internal Medicine, Seoul National University, College of Medicine, Lung Institute of Seoul National University Medical Research Center)
Shim, Young Soo (Department of Internal Medicine, Seoul National University, College of Medicine, Lung Institute of Seoul National University Medical Research Center)
Lee, Jae Ho (Department of Internal Medicine, Seoul National University, College of Medicine, Lung Institute of Seoul National University Medical Research Center)
Publication Information
Tuberculosis and Respiratory Diseases / v.63, no.4, 2007 , pp. 346-352 More about this Journal
Abstract
Background: Pulmonary hypertension is one of the cardiovascular complications of in COPD. However, a diagnosis of pulmonary hypertension requires an invasive test, such as right heart catheterization. NT-proBNP is a cardiac hormone that is elevated when a cardiac volume or pressure overload is present. It was hypothesized that NT-proBNP might play a role in detecting of pulmonary hypertension in COPD patients. Method: The 31 COPD patients, who underwent all of NT-proBNP, echocardiography, and spirometry in Seoul National University Bundang Hospital during the period from November 2003 to July 2005, were retrospectively analyzed. Result: Of the 31 COPD patients, 9 patients had pulmonary hypertension. A significant positive correlation was observed between the NT-proBNP and pulmonary arterial pressure (r=0.589, p=0.002). However, there was no significant correlation observed between the $FEV_1$ and NT-proBNP and $FEV_1$ and pulmonary arterial pressure. Conclusion: NT-proBNP might indicate the presence of pulmonary hypertension in COPD patients.
Keywords
Chronic obstructive pulmonary disease; Pulmonary hypertension; Natriuretic peptide; NT-proBNP;
Citations & Related Records

Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 National Heart, Lung, and Blood Institute and World Health Organization. Global initiative for chronic obstructive lung disease: global strategy for the diagnosis) management, and prevention of chronic obstructive pulmonary disease. National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA [revised 2006]. Available from: URL: http://www.goldcopd.com
2 Higenbottarn T. Pulmonary hypertension and chronic obstructive pulmonary disease: a case for treatment. Proc Am Thorac Soc 2005;2:12-9
3 Naeije R, Barbera JA. Pulmonary hypertension associated with COPD. Crit Care 2001;5:286-9   DOI   ScienceOn
4 Lee-Chiong Jr TL , NMthay RA. Pulmonary hypertension and cor pulmonale in COPD. Semin Respir Crit Care Med 2003;24:263-72   DOI   ScienceOn
5 Arcasoy SM, Christie JD, Ferrari VA, Sutton MS, Zisman DA, Blumenthal NP, et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 2003;167:735-40   DOI   ScienceOn
6 Bossone E, Bodini BD, Mazza A, Allegra L Pulmonary arterial hypertension: the key role of echocardiography. Chest 2005;127:1836-43   DOI   ScienceOn
7 Clerico A, Emdin M Diagnostic accuracy and plugnostie relavance of measurement of cardiac natriuretic peptkdes: a review. Clin Chem 2004;50:33-50   DOI   ScienceOn
8 Ishii J, Nomura M, lto M, Naruse H, Mori Y, Wang JH, et al. Plasma concentration of brain natriuretic peptide as a biochemical marker for evaluation of right ventricular overload and mortality in chronic respiratory disease. Clin Chim Acta 2000;301:19-30   DOI
9 McQuillan BM, Picard MH, Leavitt M, Weyman AE. Clinical oorlelates and reference intervals for pulmonary arterial systolic pressure among echocar-diographically normal subjects. Circulation 2001;104:2797-802   DOI   ScienceOn
10 Kessler R, Faller M, Weilzenhlum E, Chaouat A, Aykut A, Ducolone A, et al. 'Natural history' of pulmonaty hypertension in a series of 131 patients with chronic obstructive lung disease. Am J Respir Crit Care Med 2001;164:219-24   DOI   ScienceOn
11 Renzetti AD Jr, McClement JH, Litt ED. The Veterans Administration cooperative study of pulmonary function, 3. Mortality in relation to respiratory function in chronic obstructive pulmonary disease. Am J Med 1966;41:115-29   DOI   ScienceOn
12 Nagaya N, Nishilcimi T, Okano Y, Uematsu M, Satoh T, Kyotani S, et al. PIasma brain natiruretic peptide levels increase in proportion to extent of light ventricular dysfunction in pulmonary hypertension. J Am Coli Cardiol 1998;31:202-8   DOI
13 Scharf SM, Iqbal M, Keller C, Criner G, Lee S, Fessler HE; National Emphysema Treatment Trial (NETT) Research Group. Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med 2002;100:314-22
14 Bando M, Ishii Y, Sugiyama Y, Kitamura S. Elevated plasma brain natriuretic peptide levels in chronic respiratory failure with cor pulmonale. Respir Med 1999;93:507-14   DOI   ScienceOn
15 Barbera JA, Peinado VI, Santos S. Pulmonary hypertension in chronic obstructive pulmonary disease. Eur Respir J 2003;21:892-905   DOI   ScienceOn
16 Ueda R, Yokouchi M, Suzuki T, aromo E, Katagiri T. Prognostic value of high plasma brain natriuretic peptide concentrations in very elderly persons. Am J Med 2003;114:266-70   DOI   ScienceOn
17 Voelkel NF, Cool CD. Pulmonary vascular involvement in chronic obstructive pulmonary disease. Eur Respir J Suppl 2003;46:28S-32S
18 Kim DB, Kim YS, Jung K-S, Chang JH, Lim CM, Lee JH, et a1. Prevalence of chronic obstructive pulmonary disease in Korea. Am J Respir Crit Care Med 2005;172:842-7   DOI   ScienceOn
19 Nagaya N, Nishikimi T, Uematsu M, Satoh T, Kyotani S, Sakamaki P, et al. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation 2000;102:865-70   DOI   ScienceOn
20 Agusti AG, Noguem A, Sauleda J, Sala E, Pons J, Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 2003;21:347-60   DOI   ScienceOn
21 Naeije R. Pulmonary hypertension and right heart failure in chronic obstructive pulmonary disease. Proc Am Thome Soc 2005;2:20-2
22 Ruskoaho H Caridac hormones as diagnostic tools in heart failure. Endocr Rev 2003;24:341-66   DOI   ScienceOn
23 Chaouat A, Bugnet A, Kadaoui N, Schott R, Enache I, Thlcolone A, et al. Severe pulmonary hypertension and clu'Onic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;172:189-94   DOI   ScienceOn
24 Weitzenblun E, Chaouat A. Severe pulmonary hypertension in com is it a distinct disease? Chest 2006;127:1480-2   DOI   ScienceOn
25 Mitchell RS, Vincent Th, Ryan S, Pilley GP. Chrunic obstructive bronchopubnonary disease, IV: 'The clinical and physiological difference of chronic bronchitis and emphysema. Am J Med Sci 1964;247:513-7   DOI   ScienceOn
26 Yap LB, rvlukerjee D, Timms PM, Ashrafjan H, Coghlan JG.. Natriuretic peptides, respiratory disease, and right heart. Chest 2004;126:1330-6   DOI   ScienceOn
27 Barst RJ, McGoon M, Torbicki A, Sitbon O, Krowka MJ, Olschewski H, et al. Diagnosis and differential assessment of pulmonaty arterial hypertension. J Am Coli Cardiol 2004;43:408-78
28 Kim NH. Diagnosis and evaluation of patient with pulmonaty hypertension. Cardiol Clin 2004;22:367-73   DOI   ScienceOn